Chaiyaprasithi B, Mang C F, Kilbinger H, Hohenfellner M
Department of Urology, University of Mainz, Mainz, Germany.
J Urol. 2003 Nov;170(5):1897-900. doi: 10.1097/01.ju.0000091870.51841.ae.
Stimulating muscarinic receptors in pig bladder urothelium causes the release of a diffusable factor that inhibits contractions of the underlying detrusor muscle. We investigated whether the contractions of human detrusor strips elicited by the muscarinic agonist carbachol, electrical field stimulation, KCl or the neurokinin receptor agonist neurokinin A are affected by the urothelium.
Paired intact and urothelium denuded muscle strips were placed in modified gassed Tyrode's solution at 37C. Cumulative concentration-response curves to carbachol or KCl were constructed. In other tissues the strips were stimulated electrically (1 to 40 Hz) with trains of square wave pulses 20 seconds in duration at 5-minute intervals.
Cholinergic contractions evoked by electrical field stimulation at 10 and 30 Hz or by carbachol were significantly inhibited in the presence of an intact urothelium. Contractions elicited by KCl and by 10 microM neurokinin A were not modified by the urothelium. The urothelium mediated inhibition of contractions induced by carbachol was not affected by 300 microM L-NG-nitroarginine, 1 microM ODQ (1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one), 1 microM propranolol or 5 microM indomethacin.
Muscarinic agonists stimulate the release of an inhibitory factor from the human urothelium. The factor is distinct from nitric oxide and it persists in the presence beta-adrenoceptor blockade or cyclooxygenase inhibition.
刺激猪膀胱尿路上皮中的毒蕈碱受体可导致一种可扩散因子的释放,该因子可抑制其下方逼尿肌的收缩。我们研究了毒蕈碱激动剂卡巴胆碱、电场刺激、氯化钾或神经激肽受体激动剂神经激肽A引起的人逼尿肌条收缩是否受尿路上皮的影响。
将完整的和去除尿路上皮的成对肌条置于37℃的改良通氧台氏液中。构建对卡巴胆碱或氯化钾的累积浓度-反应曲线。在其他组织中,每隔5分钟用持续20秒的方波脉冲串以1至40赫兹的频率对肌条进行电刺激。
在完整尿路上皮存在的情况下,10赫兹和30赫兹电场刺激或卡巴胆碱引起的胆碱能收缩受到显著抑制。氯化钾和10微摩尔神经激肽A引起的收缩不受尿路上皮的影响。尿路上皮介导的对卡巴胆碱诱导收缩的抑制不受300微摩尔L-NG-硝基精氨酸、1微摩尔ODQ(1H-[1,2,4]恶二唑并[4,3-α]喹喔啉-1-酮)、1微摩尔普萘洛尔或5微摩尔吲哚美辛的影响。
毒蕈碱激动剂刺激人尿路上皮释放一种抑制因子。该因子不同于一氧化氮,并且在β-肾上腺素能受体阻断或环氧化酶抑制存在的情况下仍然存在。